[260 pages Report] The global Measurement Technology in Downstream Processing Market was valued at USD 5.0 Billion in 2022 and is expected to reach USD 7.2 Billion by 2028, with, finds Future Market Insights in a recent market survey.
Increasing prevalence of chronic illnesses, especially cardiovascular diseases, cancers, and diabetes across the globe have been the prime reason for investment in biologics market. Rising demand for biologics due to higher efficacy and fewer side effects compared to small molecule drugs give demand for biopharmaceutical production. The preference for purified biopharmaceuticals products has led to the rising demand for purification of modified therapeutic products market.
Precised results required in bioprocessing from past few years has increased the demand for biomedical sensors, device and measurement systems market. Sensor design has also evolved in order to keep pace with the rapidly changing demand of the industry which has created demand for biosensors market. Highly accurate measurement device are required for protein detection which can boost the protein detection quantification market.
Biopharmaceutical downstream process market are generally dominated by chromatographic separations and membrane filtrations for biological products. Thereby, rising the demand for nucleic acid isolation and purification market.
As a majority of activities in biotechnology and life science research are dependent on collaboration and funding’s. Additionally, due to the strong distribution, several players in the market make their products available around the world using various retailers and distributors.
For instance, in May 2020, Hamilton Company announced that its process analytics (sensors) unit was transitioning to a direct sales model throughout most of the USA and Canada.
In addition, protein molecule has various advantages like high specificity, low toxicity and complex functions which are highly adopted by researcher and biopharma industries. Thus, driving the market for proteomics market.
The increase in capacity demands have resulted in equipment needs for bioprocessing, which is only expected to gain further traction over the forecast period. Hence, the demand for measurement sensors is likely to stay high over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 6.09% |
| H1, 2022 Projected | 6.15% |
| H1, 2022 Outlook | 6.05% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 4 ↓ |
A comparative analysis about the market growth rates and development prospects in the global measurement technology in downstream processing market has been presented by FMI. The market is subject to be influenced by regulatory approvals for biologics and innovation factors in accordance with impact of macro and industry factors.
Online digital holographic microscopy when monitoring a bioreactor culture, and nano-plasmonic sensing are major progresses in this market.
As per the analysis by Future Market Insights, the market will decrease by 4 Basis Point Share (BPS) between H1-2021 and H1-2022(O). Major reasons for this decrease in BPS is attributed to the presence of flocculants during downstream processing of pharmaceutical proteins, impacting quality by design aspects of process development.
The market witnessed a decline in growth rate by 10 BPS between the periods of H1-2022 outlook over H1-2022 projected.
Other market segments are set to perform fairly and attain promising growth prospects in the next half of projection period. There are some relevant deterrent points that affect the industry growth, including the market entry of biosimilars and increasing costs in research and development of new drugs.
In addition, rising costs per approved drug and reduced sales of off-patent blockbuster drugs due to price competition from a variety of biosimilar competitors might affect the growth of the measurement technology in downstream processing market.
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 4.7 billion |
| Forecasted Global Market Value (2028) | USD 7.2 billion |
| Market Growth Rate 2022-2028 | 6.1% |
| Top 5 Countries % Share | 58.3% |
| Key Players | Companies are like Applikon Biotechnology Inc.; Sartorius AG; Broadley-James Corporation; Thermo Fisher Scientific Inc.; Hamilton Company give 8% market share. |
Principal Consultant
Sales of measurement technology in downstream processing market grew at a CAGR of 5.6% between 2012 and 2021.
There is a high demand for high precision, continuous feedback sensors in bioprocessing to get precise results. Several standard operating procedures (SOPs) call for continuous feedback and process control for measuring key parameters such as pH, DO, temperature etc. This create demand for sensors in measurement technology in downstream processing market.
New and innovative sensor technologies and smart bioprocess control equipment can enhance process development at the bench or lab scale and lead to a better route to scale up operations. In larger scale operations, especially in commercial manufacturing, GMP regulations apply due to which process deviations can result in significant losses to revenue and production thus creating the need for precise measuring devices.
Therefore, the use of improved sensor technology is crucial in optimizing processing parameters and thus is likely to drive the growth of measurement technology in downstream processing market.
Considering this, it is expected for the global measurement technology in downstream processing market to grow at a CAGR of 6.1% through 2028.
High failure rates in conventional sensors limiting use in large-scale applications is expected to hamper the growth of market over the forecast period. Conventional sensors such as electrochemical DO probes have exhibited high failure rates due to deposition at the membrane where process liquid contact occurs.
Continuous biopharmaceutical manufacturing may be consistent with FDA’s Quality by Design (QbD) efforts, but there is still untapped potential for manufacturers of bioprocessing equipment to improve product quality assurance.
Sensors contributes in providing product quality, lowering the manufacturing cycle time, and reducing capital costs & time by stabilizing bioprocessing operations. So, failure of this sensors may result in declining the market growth to some extent for the Measurement technology in downstream processing market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The USA is estimated to account for over 95.3% of the North America measurement technology in downstream processing market demand in 2022. High adoption rate of automated in bioprocessing system.
Many bioprocessing vendors in USA are adopting developed technologies that typically address automation challenges, extending from software development and integration, to continuous process. Accessibility of technical resources and an enhanced knowledge to improve the quality of research and success rates, thereby bringing more novel therapeutics to the market.
Germany is estimated to account for 34.5% market share in Europe in 2022. Factors such as increase in presence of research and development program, adequate research infrastructure with satisfactory results for biologics is boosting the demand for measurement technology in downstream processing market in Germany.
To enable collaboration and cross-functional research and development, several different for-profit and not-for-profit agencies have come forth to bringing innovative therapeutic biological options for chronic disease. This bring positive growth for market in Germany.
China is estimated to account for 49.8% of the East Asia market by 2022 owing to shift of investment in R&D and technology, especially in the life sciences, from North America and Europe to Asia Pacific.
China government have started taking initiatives to support growth of the local biotechnology industry by offering tax exclusions for R&D, increased budgets and funding’s. So more focus is generated to develop effective measuring tool for biological products for measurement technology in downstream processing market.
Demand for measurement technology in downstream processing market in India is expected to rise at an impressive growth opportunities with 9.6% CAGR over the forecast period.
Developing countries like India have ample qualified manpower and skilled labor at reasonable costs thereby raising the scope for attracting outsourcing of biotechnology projects this is responsible for the growth of the market in India.
By Product, the sensors segment is anticipated to hold the maximum share of 49.8% in 2022. Sensors play important role in biological production and technological advancement in sensor which will give boost to market.
Life science and downstream processing technology have moved to a great extent of sensing and automated process control as new technologies including wireless sensors such as VisiPro DO sensor, Contactless optical DO sensors etc. are introduced in the market. This provides huge opportunity for product business to existing players in the market
This advanced sensors are highly adopted by researcher and biopharmaceutical companies, due to which there is a significant demand for sensors over the forecast period.
Demand for single-use by modality are expected to rise at an impressive 6.9% CAGR over the forecast period. Due to its numerous advantage of single-use unit measurement technology in downstream processing for step by steps detection in various analytical system as well as optimization, and elimination of standardization steps, the market is witness growth during the forecast period.
Moreover, single-use measuring products are rapidly becoming commonplace at not just the lab or bench scale, but also at commercial scale due to ease of use and limited potential for cross-contamination which give global traction to measurement technology in downstream processing market.
By end user, pharmaceutical & biotechnology company segment lead the market with market share of 42.8% in 2022. Most of the pharma and biopharma players focus in collaboration with research institutes to increase their product portfolio.
Moreover, most of companies’ revenue is spend towardss research and development department where measuring tool is highly used. So, large biopharmaceutical companies hold large share in measurement technology in downstream processing market.
Companies operating in the measurement technology in downstream processing market devices are actively seeking to strengthen their position through expansion, and merger & acquisition, with established as well as emerging market players.
Some of the recent instances include:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | USD Billion for Value and Volume in Unit |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, BENELUX, Russia, Poland, Nordic, China, Japan, South Korea, India, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product, Modality, End User and Region |
| Key Companies Profiled | Applikon Biotechnology Inc.; Sartorius AG; Broadley-James Corporation; Thermo Fisher Scientific Inc.; Hamilton Company; Waters Corporation; PreSens Precision Sensing GmbH; PendoTECH LLC; Endress+Hauser AG; Mettler-Toledo International Inc.; Metroglas AG; Madison; YSI; Evoqua; Sensorex; Forbes |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global measurement technology in downstream processing market is worth USD 4.7 Billion in 2021 and is set to expand with CAGR of 6.1% over forecast period.
The market is expected to reach USD 7.2 Billion by the end of 2028.
The sales of measurement technology in downstream processing market have grown at a CAGR of nearly 5.6% between 2012 and 2021.
USA, Germany, UK, china and japan are the top 5 countries that are driving the demand for Tinnitus Management.
Western Europe is one of the key region dominating with 40.5% market share in 2022.
1. Executive Summary 2. Market Introduction 3. Market Viewpoint 4. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2028 5. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2028 6. Western Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2028 7. Eastern Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2028 8. Asia Pacific excluding Japan Market Analysis 2012 to 2021 and Forecast 2022 to 2028 9. Japan Market Analysis 2012 to 2021 and Forecast 2022 to 2028 10. Middle East & Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2028 11. Competition Landscape 11.1. Applikon Biotechnology, Inc. 11.2. Broadley-James Corporation 11.3. Endress+Hauser AG 11.4. Thermo Fisher Scientific 11.5. Hamilton Company 11.6. Mettler-Toledo International, Inc. 11.7. PendoTECH 11.8. PreSens Precision Sensing GmbH 11.9. Sartorius AG 12. Global Market Analysis and Forecast, By Region 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. Asia Pacific Excl. Japan (APEJ) 12.6. Japan 12.7. Middle East and Africa (MEA) 13. Global Market Analysis and Forecast, By Product Type 13.1. Sensors 13.1.1. pH Sensors 13.1.1.1. Optical 13.1.1.2. Electrochemical 13.1.2. Dissolved Oxygen (DO) Sensors 13.1.2.1. Optical 13.1.2.2. Electrochemical 13.1.3. ORP Sensors 13.1.4. Conductivity Sensors 13.1.5. Cell Density Sensors 13.2. Transmitters and Controllers 13.3. Sensor Housings 13.4. Cables and Connectors 13.5. Buffers and Standard Reagents 14. Global Market Analysis and Forecast, By Modality 14.1. Single-use 14.2. Reusable 15. Global Market Analysis and Forecast, By End User 15.1. Biopharmaceutical Companies 15.2. Food & Beverage Companies 15.3. Contract Manufacturing Organizations 15.4. Academic and Research Institutes 15.5. Others 16. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2028 17. Assumptions and Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Measurement Technology in Downstream Processing Market
